Tool: DupCheckTool: DupCheck

www.DupCheck.org is a web-based tool to screen for duplicate patients in clinical trials within and across studies, sponsors and therapeutic areas. Please visit our "Tools" page for more information.


Project FlyerProject Flyer


Click here to download 
the NEWMEDS project flyer! 


ConsortiumConsortium
consortium teaser

QuicklinksQuicklinks
Project Office Project Office Annual PGB and WP Leads Meetings Annual PGB and WP Leads Meetings Project Governance Project Governance Funding Mechanisms Funding Mechanisms




  Members Area
Username:
Password:



EU
IMI | The Innovative Medicines Initiative
EFPIA | European Federation of Pharmaceutical Industries and Associations

Lundbeck

H. Lundbeck A/S
Ottiliavej 9
2500 Valby
Denmark

Lundbeck www.lundbeck.com



Participant's Lead


Tine Bryan Stensbøl Tine Bryan Stensbøl
Divisional Director 
E-Mail to Tine Bryan Stensbøl Contact  
 



Institute Presentation


Lundbeck is a global CNS specialised pharmaceutical company with active programs in Psychiatry areas relevant to this project. Lundbeck personnel have expertise in a number of areas that will support this project:
- Expertise in development of animal disease models and tests within Schizophrenia and Depression.
- Expertise in medicinal chemistry efforts leading to putative PET ligands.
- Expertise in CIAS study design.
- Expertise in pharmacogenomics approaches, including genetic, transcription, and biostatistics analysis.
Lundbeck also has an active clinical sample repository with samples available for use by this project.


01 H Lundbeck A/S